GLPG: Galapagos NV – Depositary Receipt (Common Stock) Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 2,795.57
Book Value / Share 42.42
Price / Book n/a
NCAV ($M) 2,299.76
NCAV / Share 34.90
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.08
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.08

Liquidity (mrq)
Quick Ratio 8.84
Current Ratio 9.02

Balance Sheet (mrq) ($M)
Current Assets 3,861.59
Assets 4,357.40
Liabilities 1,561.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 239.72
Operating Income -88.26
Net Income 211.70

Cash Flow Statement (mra) ($M)
Cash From Operations -405.97
Cash from Investing 71.19
Cash from Financing -5.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A EcoR1 Capital, LLC 9.90 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 47,353 269,304 17.58
2024-03-27 9,875 22,193 44.50
2024-03-26 6,360 66,331 9.59
2024-03-25 18,965 103,475 18.33

(click for more detail)

Similar Companies
ABCL – AbCellera Biologics Inc. ABOS – Acumen Pharmaceuticals, Inc.
ABUS – Arbutus Biopharma Corporation ACAD – ACADIA Pharmaceuticals Inc.
ACLX – Arcellx, Inc.


Financial data and stock pages provided by
Fintel.io